EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, BNGO: Bionano Genomics Inc

22 Oct 25 15:59
LAST:

1.940

CHANGE:
 0.02		OPEN:
1.890		HIGH:
1.950		ASK:
0.000		VOLUME:
315.9K
CHG(%):
1.05		PREV:
1.900		LOW:
1.850		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Oct 251.8901.9401.8501.920361.9K
21 Oct 251.9601.9701.8901.900369.6K
20 Oct 251.9602.0191.9401.980379.1K
17 Oct 251.9401.9841.8901.900447.2K
16 Oct 252.1202.1501.9901.990378.4K
15 Oct 252.1102.1552.0412.115455.7K
14 Oct 251.9302.1201.9102.090555.7K
13 Oct 251.9702.0101.9001.960522.2K
10 Oct 252.1102.1271.9351.950670.6K
09 Oct 251.9902.1501.9902.130701.4K

COMPANY PROFILE

Name:Bionano Genomics Inc
About:Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for analysis and interpretation of genomic data from microarray and sequencing data for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:9540 Towne Centre Drive, San Diego, CA, United States, 92121
Website:https://bionano.com
CUSIP:09075F206
CIK:0001411690
ISIN:US09075F3055
FIGI:BBG001KWWRS9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.940.1%
MA10:1.992.8%
MA20:1.921.3%
MA50:2.7541.8%
MA100:3.0557.0%
MA200:3.3773.9%
STO9:7.84 
STO14:7.84 
RSI14:51.36
WPR14:-91.30 
ATR:0.13 
Week High:2.1611.1%
Week Low:1.854.9%
Month High:2.1611.1%
Month Low:1.6373.9%
Year High:6.98259.8%
Year Low:0.121,578.2%

RECENT SPLITS

Date Ratio
27 Jan 20251-60
07 Aug 20231-10